Faster rate of regulatory approvals for canine separation anxiety treatments with developments in behavioral modification applications are key to growth in the sector.
Faster rate of regulatory approvals for canine separation anxiety treatments with developments in behavioral modification applications are key to growth in the sector.
Fact.MR, Rockville MD: Market research firm Fact.MR’s ongoing report on the canine separation anxiety treatments market has projected positive growth prospects through 2021 and beyond. Resumption of elective veterinary services as the covid-19 pandemic winds down will aid recovery in the industry. Further, the lockdown restrictions have potentially reduced symptoms of separation anxiety for pets, which restricted opportunities for canine separation anxiety treatment developers for the foreseeable future.
According to the University of Illinois, College of Veterinary Medicine, up to 40% of pet dogs suffer from canine separation anxiety treatment. Treatments often include a combination of medications, interactive toys, behavioral modification, environmental changes, and audio-visual tools to alleviate emotional responses in animals.
Diagnosis for the condition is increasingly being conducted through the use of cognitive bias testing procedures. This relies extensively on background affective state parameters, which has emerged as key aspect of research in the field. Government efforts, in collaboration with non-profit organizations, have led to significant investments towards drug and therapeutic development options especially with the presence of numerous rescue kennels running in countries around the globe, which generate demand for novel treatment options.
“Rapidly growth of the global population of pets and the trend of humanization of animals are key factors that are bolstering developments in the canine separation anxiety treatments market. Also, growing public awareness about advancements in animal behavioral therapy and increasing veterinary professionals in emerging economies is expected to increase demand for canine separation anxiety treatments for years to come,” comments a Fact.MR analyst.
Request a report sample to gain detailed insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=1490
Key Takeaways from Fact.MR’s Canine Separation Anxiety Treatments Market
- Clomipramine and associated generics are expected to hold the lead, owing to higher efficacy in treatment outcomes.
- Veterinary clinics remain major contributors to revenue owing to easier access to prescription formulations for pet owners.
- Behavior modification therapy will reflect strong adoption, major investments into clinical trials for canine psychological studies.
- Higher levels of awareness among pet owners is holding United States in the lead for adopting canine separation anxiety treatments.
- China will create lucrative opportunities for market players driven by strong rise in pet population and investments into veterinary research.
- UK and France will display strong uptake on the back of favorable reimbursement and health awareness scenarios.
Canine Separation Anxiety Treatments Market – Prominent Drivers
- High incidence of separation anxiety (20 to 40%) among dogs is a major factor driving demand for treatment options.
- The rising research endeavors into cognitive bias testing has resulted in wider potential for pet healthcare treatment innovations.
- Rapid growth in the number of skilled professionals operating in the industry is likely to drive prescription and therapeutic activity in the market.
Canine Separation Anxiety Treatments – Key Restraints
- The high costs of associated with veterinary care are expected to hold back sales in the industry.
- Lack of awareness about canine separation anxiety and associated treatments especially in developing countries have hampered overall scope for growth.
Discover more about the canine separation anxiety treatments market with figures data tables and table of contents. You can also find detailed market segmentation at https://www.factmr.com/report/1490/canine-separation-anxiety-treatment-market
Competitive Landscape
Leading players in the canine separation anxiety treatments market include Merck & Co., Inc., Zoetis, Vets4Pets Limited, Pegasus Laboratories, Inc., and Pfizer Limited among others.
Strategic acquisitions and mergers are key strategies used by major market players. For example, Elanco Animal Health announced FTC approval for its acquisition of Bayer’s animal health division for a value of US$ 7.6 billion in July 2020.
Also, investments into product development and launches will remain a major strategy to consolidate their position in a fairly nascent market. For instance, SubThreshold launched its services for consumer worldwide including online, remote training for dogs suffering from separation anxiety for customized therapeutic solutions.
More Insights on the Canine separation anxiety treatments Market
In its latest report, Fact.MR offers unbiased analysis of the global canine separation anxiety treatments market. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of drug type (alprazolam, amitriptyline, buspirone, clomipramine, dexmedetomidine, diazepam, and others) and distribution channel (veterinary hospitals, veterinary clinics, pharmacies & drug stores, and others) across seven regions (North America, Latin America, Europe, Japan, Asia Pacific excluding Japan, and Middle East & Africa).
Request more information about Report Methodology
https://www.factmr.com/connectus/sample?flag=RM&rep_id=1490
Explore Fact.MR’s Coverage on the Healthcare Domain
Canine Influenza Treatment Market: A recent study by Fact.MR on the canine influenza treatment market offers a 10-year forecast for 2018 to 2028. The study analyzes key trends that are currently determining the growth of the market. This report covers vital dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.
Veterinary Respiratory Ventilators Market: Fact.MR’s extensive coverage on the veterinary respiratory ventilators market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the landscape.
Veterinary Suture Kit Market: The global veterinary suture kit market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities and trends expected to shape future expansion outlook. The report provides a comprehensive assessment on the prominent segments and geographies which are likely to benefit market players in forthcoming years.
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Source: Fact.MR